Literature DB >> 21325363

Comparison of diamond-like carbon-coated nitinol stents with or without polyethylene glycol grafting and uncoated nitinol stents in a canine iliac artery model.

J H Kim1, J H Shin, D H Shin, M-W Moon, K Park, T-H Kim, K M Shin, Y H Won, D K Han, K-R Lee.   

Abstract

OBJECTIVE: Neointimal hyperplasia is a major complication of endovascular stent placement with consequent in-stent restenosis or occlusion. Improvements in the biocompatibility of stent designs could reduce stent-associated thrombosis and in-stent restenosis. We hypothesised that the use of a diamond-like carbon (DLC)-coated nitinol stent or a polyethylene glycol (PEG)-DLC-coated nitinol stent could reduce the formation of neointimal hyperplasia, thereby improving stent patency with improved biocompatibility.
METHODS: A total of 24 stents were implanted, under general anaesthesia, into the iliac arteries of six dogs (four stents in each dog) using the carotid artery approach. The experimental study dogs were divided into three groups: the uncoated nitinol stent group (n = 8), the DLC-nitinol stent group (n = 8) and the PEG-DLC-nitinol stent group (n = 8).
RESULTS: The mean percentage of neointimal hyperplasia was significantly less in the DLC-nitinol stent group (26.7±7.6%) than in the nitinol stent group (40.0±20.3%) (p = 0.021). However, the mean percentage of neointimal hyperplasia was significantly greater in the PEG-DLC-nitinol stent group (58.7±24.7%) than in the nitinol stent group (40.0±20.3%) (p = 0.01).
CONCLUSION: Our findings indicate that DLC-coated nitinol stents might induce less neointimal hyperplasia than conventional nitinol stents following implantation in a canine iliac artery model; however, the DLC-coated nitinol stent surface when reformed with PEG induces more neointimal hyperplasia than either a conventional or DLC-coated nitinol stent.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325363      PMCID: PMC3473868          DOI: 10.1259/bjr/21667521

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  19 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  Comparison of a microporous thermoplastic polyurethane-covered stent with a self-expanding bare nitinol stent in a porcine iliac artery model.

Authors:  Boris Radeleff; Lars Grenacher; Patricia Christoph; Christof M Sommer; Ulrike Stampfl; Stefanie Ramsauer; Tina Henn; Patrick Kurz; Ruben Lopez-Benitez; Irina Berger; Goetz M Richter
Journal:  J Vasc Interv Radiol       Date:  2009-06-04       Impact factor: 3.464

3.  Update on In-stent Restenosis.

Authors:  Magdi M. El-Omar; George Dangas; Ioannis Iakovou; Roxana Mehran
Journal:  Curr Interv Cardiol Rep       Date:  2001-11

4.  Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery.

Authors:  Martin Schillinger; Schila Sabeti; Christian Loewe; Petra Dick; Jasmin Amighi; Wolfgang Mlekusch; Oliver Schlager; Manfred Cejna; Johannes Lammer; Erich Minar
Journal:  N Engl J Med       Date:  2006-05-04       Impact factor: 91.245

5.  Clinical and angiographic outcome after coronary arterial stenting with the carbostent.

Authors:  D Antoniucci; A Bartorelli; R Valenti; P Montorsi; G M Santoro; F Fabbiocchi; L Bolognese; A Loaldi; M Trapani; D Trabattoni; G Moschi; S Galli
Journal:  Am J Cardiol       Date:  2000-04-01       Impact factor: 2.778

6.  Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study.

Authors:  Antonio L Bartorelli; Daniela Trabattoni; Piero Montorsi; Franco Fabbiocchi; Stefano Galli; Paolo Ravagnani; Luca Grancini; Sergio Cozzi; Alessandro Loaldi
Journal:  Catheter Cardiovasc Interv       Date:  2002-02       Impact factor: 2.692

7.  Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results.

Authors:  Stephan H Duda; Benjamin Pusich; Goetz Richter; Peter Landwehr; Vincent L Oliva; Alexander Tielbeek; Benjamin Wiesinger; Jan Bart Hak; Hans Tielemans; Gerhard Ziemer; Ecatarina Cristea; Alexandra Lansky; Jean P Bérégi
Journal:  Circulation       Date:  2002-09-17       Impact factor: 29.690

8.  Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience.

Authors:  Petra Dick; Schila Sabeti; Wolfgang Mlekusch; Oliver Schlager; Jasmin Amighi; Markus Haumer; Manfred Cejna; Erich Minar; Martin Schillinger
Journal:  Radiology       Date:  2008-07       Impact factor: 11.105

9.  Success, safety, and efficacy of implantation of diamond-like carbon-coated stents.

Authors:  Anastasios Salahas; Antonios Vrahatis; Ilias Karabinos; Ioannis Antonellis; Georgios Ifantis; Isidoros Gavaliatsis; Prodromos Anthopoulos; Antonios Tavernarakis
Journal:  Angiology       Date:  2007 Apr-May       Impact factor: 3.619

10.  Electrochemical and microstructural studies of tantalum and its oxide films for biomedical applications in endovascular surgery.

Authors:  R A Silva; M Walls; B Rondot; M Da Cunha Belo; R Guidoin
Journal:  J Mater Sci Mater Med       Date:  2002-05       Impact factor: 3.896

View more
  3 in total

Review 1.  Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy.

Authors:  Aleena Mary Cherian; Shantikumar V Nair; Vijayakumar Maniyal; Deepthy Menon
Journal:  APL Bioeng       Date:  2021-06-01

2.  On the potential for fibronectin/phosphorylcholine coatings on PTFE substrates to jointly modulate endothelial cell adhesion and hemocompatibility properties.

Authors:  Vanessa Montaño-Machado; Pascale Chevallier; Diego Mantovani; Emmanuel Pauthe
Journal:  Biomatter       Date:  2015

Review 3.  Diamond thin films: giving biomedical applications a new shine.

Authors:  P A Nistor; P W May
Journal:  J R Soc Interface       Date:  2017-09       Impact factor: 4.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.